Antibacterial bioactive glass for European markets
Two new products have been approved to European medical markets: antibacterial bioactive glass granules for remedying frontal sinus and bone defects and a bioactive glass plate for the repair of the orbital floor.
The products, registered by a Finnish biomaterials company Vivoxid Ltd are aimed at solving medical problems in the head and neck area.
Bioactive glass products hold substantial commercial potential. Bioactive glass offers a number of new application areas in the future in medicine and dentistry. Vivoxid has a wide development programme of new bioactive glass products. Tekes, the National Technology Agency of Finland, has funded Vivoxid’s R&D work.
“The first scientific studies with bioactive glass were conducted, as early as the middle of the 80’s at Åbo Akademi University (Turku, Finland) and at the University of Turku. The present achievement has been preceded by thorough clinical research at the University Hospital of Turku for over ten years”, says Vivoxid’s CEO Kauko Kurkela.
Vivoxid’s products can be used for curing frontal sinus and bone defects in the treatment of chronic infections of the frontal sinus. The material enhances the growth of new bone, sustains the formed bone and has antibacterial effects. Clinical experience from the past ten years has been very positive.
One of Vivoxid’s CE approved bioactive glass products is a solid plate for the reconstruction of a bro-ken orbital floor, often caused by sporting injuries, accidents or violence, for example.
Substantial commercial potential
Around 20 000 operations are performed worldwide in both the aforementioned indications. Although the products are currently for a niche market as registered for cranial indications, they hold substantial commercial potential after being further developed for much wider indication areas such as the ortho-paedic area.
After entering the European markets, the company intends to focus on the markets in North America, Japan and other countries.
Mira Banerjee | alfa
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
Physicists have developed a new technique that uses electrical voltages to control the electron spin on a chip. The newly-developed method provides protection from spin decay, meaning that the contained information can be maintained and transmitted over comparatively large distances, as has been demonstrated by a team from the University of Basel’s Department of Physics and the Swiss Nanoscience Institute. The results have been published in Physical Review X.
For several years, researchers have been trying to use the spin of an electron to store and transmit information. The spin of each electron is always coupled...
What is the mass of a proton? Scientists from Germany and Japan successfully did an important step towards the most exact knowledge of this fundamental constant. By means of precision measurements on a single proton, they could improve the precision by a factor of three and also correct the existing value.
To determine the mass of a single proton still more accurate – a group of physicists led by Klaus Blaum and Sven Sturm of the Max Planck Institute for Nuclear...
A bacterial enzyme enables reactions that open up alternatives to key industrial chemical processes
The research team of Prof. Dr. Oliver Einsle at the University of Freiburg's Institute of Biochemistry has long been exploring the functioning of nitrogenase....
Larsen C Ice Shelf rift finally breaks through
A one trillion tonne iceberg - one of the biggest ever recorded -- has calved away from the Larsen C Ice Shelf in Antarctica, after a rift in the ice,...
Physics supports biology: Researchers from PTB have developed a model system to investigate friction phenomena with atomic precision
Friction: what you want from car brakes, otherwise rather a nuisance. In any case, it is useful to know as precisely as possible how friction phenomena arise –...